The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(2-(dimethylamino)ethyl)-3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)-N-methylbenzamide ID: ALA4127424
PubChem CID: 122438572
Max Phase: Preclinical
Molecular Formula: C18H19F3IN3O
Molecular Weight: 477.27
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CN(C)CCN(C)C(=O)c1ccc(F)c(F)c1Nc1ccc(I)cc1F
Standard InChI: InChI=1S/C18H19F3IN3O/c1-24(2)8-9-25(3)18(26)12-5-6-13(19)16(21)17(12)23-15-7-4-11(22)10-14(15)20/h4-7,10,23H,8-9H2,1-3H3
Standard InChI Key: NAILWPQZDDTXHZ-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 27 0 0 0 0 0 0 0 0999 V2000
9.3627 -5.2138 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6483 -4.8013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9338 -5.2138 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2193 -4.8013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2193 -3.9763 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9338 -3.5638 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6483 -3.9763 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3627 -6.0388 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.0772 -4.8013 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.0772 -3.9763 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9338 -6.0388 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.2193 -6.4513 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2193 -7.2763 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5049 -7.6888 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7904 -7.2763 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7904 -6.4513 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.5049 -6.0388 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0759 -7.6888 0.0000 I 0 0 0 0 0 0 0 0 0 0 0 0
7.9338 -7.6888 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
6.5049 -3.5638 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
6.5049 -5.2138 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
10.7917 -5.2138 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5062 -4.8013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2206 -5.2138 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.9351 -4.8013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.2206 -6.0388 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 7 1 0
2 7 2 0
1 8 2 0
1 9 1 0
9 10 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
12 17 2 0
15 18 1 0
13 19 1 0
11 12 1 0
3 11 1 0
5 20 1 0
4 21 1 0
22 23 1 0
24 25 1 0
24 26 1 0
23 24 1 0
9 22 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 477.27Molecular Weight (Monoisotopic): 477.0525AlogP: 4.09#Rotatable Bonds: 6Polar Surface Area: 35.58Molecular Species: NEUTRALHBA: 3HBD: 1#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.82CX Basic pKa: 8.47CX LogP: 5.39CX LogD: 4.29Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.64Np Likeness Score: -1.89
References 1. Chakrabarty S, Monlish DA, Gupta M, Wright TD, Hoang VT, Fedak M, Chopra I, Flaherty PT, Madura J, Mannepelli S, Burow ME, Cavanaugh JE.. (2018) Structure activity relationships of anthranilic acid-based compounds on cellular and in vivo mitogen activated protein kinase-5 signaling pathways., 28 (13): [PMID:29803729 ] [10.1016/j.bmcl.2018.05.029 ]